BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 28494798)

  • 1. Androstenedione response to recombinant human FSH is the most valid predictor of the number of selected follicles in polycystic ovarian syndrome: (a case-control study).
    Ozyurek ES; Yoldemir T; Artar G
    J Ovarian Res; 2017 May; 10(1):34. PubMed ID: 28494798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
    Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS
    Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].
    Parahuleva N; Pehlivanov B; Orbecova M; Deneva T; Uchikova E
    Akush Ginekol (Sofiia); 2013; 52 Suppl 1():16-23. PubMed ID: 24294740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum anti-Müllerian hormone and inhibin B concentrations are not useful predictors of ovarian response during ovulation induction treatment with recombinant follicle-stimulating hormone in women with polycystic ovary syndrome.
    Lie Fong S; Schipper I; de Jong FH; Themmen AP; Visser JA; Laven JS
    Fertil Steril; 2011 Aug; 96(2):459-63. PubMed ID: 21719005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Follicular development and hormone concentrations following recombinant FSH administration for anovulation associated with polycystic ovarian syndrome: prospective, randomized comparison between low-dose step-up and modified step-down regimens.
    Balasch J; Fábregues F; Creus M; Puerto B; Peñarrubia J; Vanrell JA
    Hum Reprod; 2001 Apr; 16(4):652-6. PubMed ID: 11278212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of androgen blockade on granulosa cell estradiol production after follicle-stimulating hormone stimulation in women with polycystic ovary syndrome.
    Mehta RV; Malcom PJ; Chang RJ
    J Clin Endocrinol Metab; 2006 Sep; 91(9):3503-6. PubMed ID: 16804036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initial estradiol response predicts outcome of exogenous gonadotropins using a step-down dose regimen for induction of ovulation in polycystic ovary syndrome.
    Schoot DC; Hop WC; de Jong FH; van Dessel TJ; Fauser BC
    Fertil Steril; 1995 Dec; 64(6):1081-7. PubMed ID: 7589656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific factors predict the response to pulsatile gonadotropin-releasing hormone therapy in polycystic ovarian syndrome.
    Gill S; Taylor AE; Martin KA; Welt CK; Adams JM; Hall JE
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2428-36. PubMed ID: 11397835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose ovulation induction with urinary gonadotropins or recombinant follicle stimulating hormone in patients with polycystic ovary syndrome.
    Szilágyi A; Bártfai G; Mánfai A; Koloszár S; Pál A; Szabó I
    Gynecol Endocrinol; 2004 Jan; 18(1):17-22. PubMed ID: 15106360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequential low-dose step-up and step-down protocols with recombinant follicle-stimulating hormone in polycystic ovary syndrome: prospective comparison with step-down protocol.
    Casadei L; Puca F; Emidi E; Manicuti C; Madrigale A; Piccione E
    Arch Gynecol Obstet; 2012 Nov; 286(5):1291-7. PubMed ID: 22729136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of oral administration of low-dose follicle stimulating hormone on hyperandrogenized mice as a model of polycystic ovary syndrome.
    Tessaro I; Modina SC; Franciosi F; Sivelli G; Terzaghi L; Lodde V; Luciano AM
    J Ovarian Res; 2015 Oct; 8():64. PubMed ID: 26437930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in serum markers of patients with PCOS during consecutive clomiphene stimulation cycles: a retrospective study.
    Hager M; Hörath S; Frigo P; Koch M; Marculescu R; Ott J
    J Ovarian Res; 2019 Oct; 12(1):91. PubMed ID: 31585548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant human follicle stimulating hormone versus human menopausal gonadotrophin induction: effects in mature follicle endocrinology.
    Teissier MP; Chable H; Paulhac S; Aubard Y
    Hum Reprod; 1999 Sep; 14(9):2236-41. PubMed ID: 10469686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The rise of estradiol and inhibin B after acute stimulation with follicle-stimulating hormone predict the follicle cohort size in women with polycystic ovary syndrome, regularly menstruating women with polycystic ovaries, and regularly menstruating women with normal ovaries.
    Elting MW; Kwee J; Schats R; Rekers-Mombarg LT; Schoemaker J
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1589-95. PubMed ID: 11297588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced intrafollicular androstenedione and estradiol levels in early-treated prenatally androgenized female rhesus monkeys receiving follicle-stimulating hormone therapy for in vitro fertilization.
    Dumesic DA; Schramm RD; Bird IM; Peterson E; Paprocki AM; Zhou R; Abbott DH
    Biol Reprod; 2003 Oct; 69(4):1213-9. PubMed ID: 12801996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive markers for the FSH sensitivity of women with polycystic ovarian syndrome.
    Köninger A; Sauter L; Edimiris P; Kasimir-Bauer S; Kimmig R; Strowitzki T; Schmidt B
    Hum Reprod; 2014 Mar; 29(3):518-24. PubMed ID: 24419495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Follicular arrest in polycystic ovary syndrome is associated with deficient inhibin A and B biosynthesis.
    Welt CK; Taylor AE; Fox J; Messerlian GM; Adams JM; Schneyer AL
    J Clin Endocrinol Metab; 2005 Oct; 90(10):5582-7. PubMed ID: 16030174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Concentration of steroid hormones in the follicular fluid of mature and immature ovarian follicles of patients with polycystic ovary syndrome submitted to in vitro fertilization].
    de Resende LO; dos Reis RM; Ferriani RA; Vireque AA; Santana LF; de Sá Rosa e Silva AC; Martins Wde P
    Rev Bras Ginecol Obstet; 2010 Sep; 32(9):447-53. PubMed ID: 21271150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cohort size rather than follicle-stimulating hormone threshold level determines ovarian sensitivity in polycystic ovary syndrome.
    Van Der Meer M; Hompes PG; De Boer JA; Schats R; Schoemaker J
    J Clin Endocrinol Metab; 1998 Feb; 83(2):423-6. PubMed ID: 9467551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accelerated follicle growth during the culture of isolated caprine preantral follicles is detrimental to follicular survival and oocyte meiotic resumption.
    Apolloni LB; Bruno JB; Alves BG; Ferreira ACA; Paes VM; Moreno JLRC; de Aguiar FLN; Brandão FZ; Smitz J; Apgar G; de Figueiredo JR
    Theriogenology; 2016 Oct; 86(6):1530-1540. PubMed ID: 27371972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.